166 related articles for article (PubMed ID: 29039348)
61. [Soluble interleukin 2 receptor (sIL-2R) in patients with esophageal carcinoma].
Duan ZF
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):17-9. PubMed ID: 8334935
[TBL] [Abstract][Full Text] [Related]
62. Relationship of IL-2, IL-2R (CD25+), soluble IL-2R and IL-4 with disease activity in SLE patients.
Cuadrado MJ; Marubayashi M; Ortega C; Fernandez-Arcas N; Garcia-Cozar F; Pena J; Sanchez-Guijo P; Santamaria M
Lupus; 1993 Aug; 2(4):257-60. PubMed ID: 8268974
[TBL] [Abstract][Full Text] [Related]
63. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients.
Lauwerys BR; Garot N; Renauld JC; Houssiau FA
Arthritis Rheum; 2000 Sep; 43(9):1976-81. PubMed ID: 11014347
[TBL] [Abstract][Full Text] [Related]
64. Increased activation of toll-like receptors-7 and -8 of peripheral blood mononuclear cells and upregulated serum cytokines in patients with pediatric systemic lupus erythematosus.
Guo Y; Chai Q; Zhao Y; Li P; Qiao J; Huang J
Int J Clin Exp Med; 2015; 8(11):20472-80. PubMed ID: 26884963
[TBL] [Abstract][Full Text] [Related]
65. Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE.
Midgley A; Thorbinson C; Beresford MW
Rheumatology (Oxford); 2012 May; 51(5):824-32. PubMed ID: 22253024
[TBL] [Abstract][Full Text] [Related]
66. Serum interleukin-2 receptor in systemic lupus erythematosus and rheumatoid arthritis.
Lee GL; Chen MY; Chuang CY; Chen CY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Feb; 21(1):16-22. PubMed ID: 3264781
[TBL] [Abstract][Full Text] [Related]
67. Defective spontaneous and bacterial lipopolysaccharide-stimulated production of interleukin-1 receptor antagonist by polymorphonuclear neutrophils of patients with active systemic lupus erythematosus.
Hsieh SC; Tsai CY; Sun KH; Tsai YY; Tsai ST; Han SH; Yu HS; Yu CL
Br J Rheumatol; 1995 Feb; 34(2):107-12. PubMed ID: 7704455
[TBL] [Abstract][Full Text] [Related]
68. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
[TBL] [Abstract][Full Text] [Related]
69. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.
Symons JA; Wood NC; Di Giovine FS; Duff GW
J Immunol; 1988 Oct; 141(8):2612-8. PubMed ID: 3262665
[TBL] [Abstract][Full Text] [Related]
70. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Kanda N; Tsuchida T; Tamaki K
Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
[TBL] [Abstract][Full Text] [Related]
71. [Evaluation of the effect of GHRH(1-44)NH2 on the secretion of interleukin-2 (IL-2) and soluble IL-2 receptor alpha (sIL-2Ralpha) from human peripheral blood mononuclear cells in vitro].
Siejka A; Stepień T; Ławnicka H; Krupiński R; Komorowski J; Stepień H
Endokrynol Pol; 2005; 56(5):773-8. PubMed ID: 16817143
[TBL] [Abstract][Full Text] [Related]
72. Increased sIL-2Rα leads to obstruction of IL-2 biological function and Treg cells differentiation in SLE patients
Long D; Yu S; Zhang L; Guo Y; Xu S; Rao Y; Huang Z; Luo Q; Li J
Front Immunol; 2022; 13():938556. PubMed ID: 36203602
[TBL] [Abstract][Full Text] [Related]
73. Increased excretion of soluble interleukin 2 receptors and free light chain immunoglobulins in the urine of patients with active lupus nephritis.
Tsai CY; Wu TH; Sun KH; Lin WM; Yu CL
Ann Rheum Dis; 1992 Feb; 51(2):168-72. PubMed ID: 1550398
[TBL] [Abstract][Full Text] [Related]
74. Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis.
Famularo G; Procopio A; Giacomelli R; Danese C; Sacchetti S; Perego MA; Santoni A; Tonietti G
Clin Exp Immunol; 1990 Sep; 81(3):368-72. PubMed ID: 2397608
[TBL] [Abstract][Full Text] [Related]
75. IL-10 production in multiple sclerosis patients, SLE patients and healthy controls: preliminary findings.
Gelati M; Lamperti E; Dufour A; Corsini E; Venegoni E; Milanese C; Nespolo A; Salmaggi A
Ital J Neurol Sci; 1997 Aug; 18(4):191-4. PubMed ID: 9323512
[TBL] [Abstract][Full Text] [Related]
76. Effect of cyclosporin A on interleukin-6 and soluble interleukin-2 receptor in patients with rheumatoid arthritis.
Crilly A; Kolta S; Dougados M; Sturrock RD; Amor B; Capell HA; Madhok R
Ann Rheum Dis; 1995 Feb; 54(2):137-9. PubMed ID: 7702403
[TBL] [Abstract][Full Text] [Related]
77. Soluble CD23 and interleukin-4 levels in autoimmune chronic active hepatitis and systemic lupus erythematosus.
al-Janadi M; al-Wabel A; Raziuddin S
Clin Immunol Immunopathol; 1994 Apr; 71(1):33-7. PubMed ID: 8137557
[TBL] [Abstract][Full Text] [Related]
78. IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE).
Bussolati B; Rollino C; Mariano F; Quarello F; Camussi G
Clin Exp Immunol; 2000 Dec; 122(3):471-6. PubMed ID: 11122257
[TBL] [Abstract][Full Text] [Related]
79. Activation of IL-6 production by UV irradiation of blood mononuclear cells from patients with systemic lupus erythematosus.
Pelton BK; Hylton W; Denman AM
Clin Exp Immunol; 1992 Aug; 89(2):251-4. PubMed ID: 1638768
[TBL] [Abstract][Full Text] [Related]
80. Cerebrospinal fluid soluble interleukin-2 receptor in cerebral lupus.
Gilad R; Lampl Y; Eshel Y; Barak V; Sarova-Pinhas I
Br J Rheumatol; 1997 Feb; 36(2):190-3. PubMed ID: 9133927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
